AFL vs SRPT · P/E 14, rev $4.12B vs rev $1.13B
Aflac Incorporated (AFL) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported AFL revenue for 2026-06-30 was $4.12B. Net income was $825.0M. Revenue was down 5.3% from 2026-03-31 to 2026-06-30. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the AFL and SRPT stock pages for the full models.
Not investment advice.